Securities code: 300942 securities abbreviation: Shenzhen Bioeasy Biotechnology Co.Ltd(300942) Announcement No.: 2022-003 Shenzhen Bioeasy Biotechnology Co.Ltd(300942)
Announcement of resolutions of the first extraordinary general meeting of shareholders in 2022
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.
Special tips:
1. The shareholders’ meeting did not veto the proposal;
2. There is no voting on supplementary proposals at this shareholders’ meeting, and it does not involve changing the resolutions adopted at previous shareholders’ meetings.
1、 Convening and attendance of the meeting
(I) convening of the meeting
1. Time of meeting:
(1) On site meeting time: 15:00 p.m. on Wednesday, January 12, 2022
(2) Online voting time: January 12, 2022; Among them, the time for online voting through the trading system of Shenzhen stock exchange is 9:15-9:25, 9:30-11:30 and 13:00-15:00 on January 12, 2022; Through the Internet voting system of Shenzhen Stock Exchange（ http://wltp.cn.info.com.cn. ）The voting time is from 9:15 a.m. to 15:00 p.m. on January 12, 2022.
2. Venue of on-site meeting: conference room of the company, 5 / F Shenzhen Bioeasy Biotechnology Co.Ltd(300942) 2-1 Liuxian 1st Road, Bao’an District, Shenzhen 3. Meeting method: combination of on-site voting and online voting
4. Convener: Board of directors
5. Moderator: Chairman
6. Legality and compliance of the meeting: the company held the ninth meeting of the second board of directors on December 27, 2021, deliberated and adopted the proposal on convening the first extraordinary general meeting of shareholders in 2022, and decided to convene the extraordinary general meeting of shareholders. The convening and convening procedures of this general meeting of shareholders comply with laws, administrative regulations, departmental rules, normative documents, the articles of association and other relevant provisions.
(II) attendance at the meeting
1. General attendance of shareholders
There are 8 shareholders and authorized representatives of shareholders attending the on-site meeting and online voting, with 288171671 representative shares, accounting for 71.88836% of the total voting shares of the company; Among them, there are 8 shareholders and authorized representatives of shareholders voting on site, with 288171671 representative shares, accounting for 71.5% of the total voting shares of the company 88836% ； There are 0 shareholders voting online, representing 0 shares, accounting for 0% of the total voting shares of the company.
2. Overall attendance of small and medium-sized investors
There are 2 small and medium-sized investors and their authorized representatives attending the on-site meeting and online voting, with 300 representative shares, accounting for 0.00007% of the total voting shares of the company; Among them, there are 2 small and medium-sized investors and their authorized representatives who vote on site, representing 300 shares, accounting for 0.00007% of the total voting shares of the company; There are 0 small and medium-sized investors voting through the Internet, representing 0 shares, accounting for 0% of the total voting shares of the company.
Small and medium-sized investors refer to shareholders other than directors, supervisors, senior managers and shareholders who individually or jointly hold more than 5% of the shares of the company.
3. Attendance / attendance of other personnel
Other persons attending the general meeting of shareholders are the directors, supervisors, Secretary of the board of directors and witness lawyers of the company, and other persons attending the general meeting of shareholders are the senior managers of the company. Some directors and senior executives went out on business and did not attend the meeting.
2、 Consideration and voting
The general meeting of shareholders considered various proposals one by one, and adopted the following proposals by combining on-site voting and online voting:
1. Deliberated and passed the proposal on by election of non employee representative supervisors
Voting results: 288171671 shares were approved, accounting for 71.88836% of the total valid voting shares attending the meeting; 0 dissenting shares, accounting for 0% of the total number of valid voting shares attending the meeting; Abstained 0 shares, accounting for 0% of the total number of valid voting shares attending the meeting.
The motion was passed.
3、 Legal opinions issued by lawyers
The shareholders’ meeting was witnessed by Lawyer Wang caizhang and lawyer Li Deqi of Guohao law firm (Shenzhen) and issued a legal opinion. The legal opinion holds that:
The convening and convening procedures of the company’s first extraordinary general meeting of shareholders in 2022, the qualifications of the convener and those attending the on-site meeting, and the voting procedures of the general meeting of shareholders comply with the provisions of relevant laws, regulations, normative documents and the articles of association. The resolutions adopted by the general meeting of shareholders of the company are legal and effective.
4、 Documents for future reference
1. Resolutions of the Shenzhen Bioeasy Biotechnology Co.Ltd(300942) 2022 first extraordinary general meeting of shareholders;
2. Legal opinion of Guohao law firm (Shenzhen) on the first extraordinary general meeting of shareholders in Shenzhen Bioeasy Biotechnology Co.Ltd(300942) 2022.
It is hereby announced.
Shenzhen Bioeasy Biotechnology Co.Ltd(300942) board of directors January 12, 2022
